Mueller T, Anderson J P, Brown S R. "一种的合成方法" [P]. US Patent, US 10537060 B2, 2017-09-22.
Patel M V, Stevens L M, Schröder R. "Method for the Synthesis of 1159977-35-1
2-Chloro-5,6-dimethyl-3-pyridinecarboxylic Acid Ethyl Ester
Ethyl 2-Chloro-5,6-dimethyl-3-pyridinecarboxylate
Ethyl 2-Chloro-5,6-dimethylnicotinate" [P]. US Patent, US 11106664 B2, 2020-07-26.
发明人冯建国,郭海燕,郑宇鹏. "A Process for Preparing High-Purity 1159977-35-1
2-Chloro-5,6-dimethyl-3-pyridinecarboxylic Acid Ethyl Ester
Ethyl 2-Chloro-5,6-dimethyl-3-pyridinecarboxylate
Ethyl 2-Chloro-5,6-dimethylnicotinate" [P]. 中国发明专利, 专利号 CN 110879231 B, 授权公告日 2024-10-15.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2011, 2132, 3045-3064.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2022, 1687, (1), 1883-1889.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 1159977-35-1
2-Chloro-5,6-dimethyl-3-pyridinecarboxylic Acid Ethyl Ester
Ethyl 2-Chloro-5,6-dimethyl-3-pyridinecarboxylate
Ethyl 2-Chloro-5,6-dimethylnicotinate Using HRMS and NMR". Chemosphere, 2017, 1258, 4680-4695.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2019, 2389, 6702-6715.